Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)	Non Small Cell Lung Cancer Metastatic	Active, not recruiting	Phase 2	2025-09-24		NCT04621188

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Intergroupe Francophone de Cancerologie Thoracique	15

34 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Angers - CHU	Angers	France	9
Annecy - CH	Annecy	France	1
Antony - Hôpital privé	Antony	France	1
AP-HP Hopital Tenon - Pneumologie	Paris	France	1
AP-HP Hôpital Ambroise Paré	Boulogne	France	1
AP-HP Hôpital Cochin	Paris	France	6
Avignon - CH	Avignon	France	6
Bordeaux - CHU	Bordeaux	France	2
Bordeaux - Institut Bergonie	Bordeaux	France	2
Bordeaux - Polyclinique	Bordeaux	France	2
Caen - CHU Côte de Nacre	Caen	France	6
Centre Hospitalier - Pneumologie	Le Mans	France	2
Centre Hospitalier de la Côte Basque	Bayonne	France	11
Centre Hospitalier du Pays d'Aix	Aix-en-Provence	France	1
Centre Hospitalier Intercommunal De Créteil	Créteil	France	20
Centre Léon Bérard	Lyon	France	77
Centre Paul Papin	Angers	France	1
Chauny - CH	Chauny	France	1
Cholet - CH	Cholet	France	3
CHRU Grenoble	Grenoble	France	3
CHU Bretonneau	Tours	France	10
CHU Toulouse - Pneumologie	Toulouse	France	2
Clermont-Ferrand - CHU	Clermont-Ferrand	France	4
Colmar - CH	Colmar	France	4
Dijon - CRLCC	Dijon	France	2

Clinical trials